Physicians recommend to administer drugs that cause serious side effects such as nausea, dizziness or sleep disorder before bed so that the patient does not feel the discomfort of those side effects during sleep.
Patients in bed
OD!FS® is optimized for drugs with serious side effects. Its convenience of administration is high, as it can be administered in bed without the patient needing to get up for water. Its formulation has increased patient compliance with physicians’ prescriptions. Ultimately, the treatment effects are enhanced.
OD!FS® is a patient-friendly formulation that can be smoothly taken with only a small amount of saliva without having water. It is most suitable for dysphagia patients.
OD!FS® is a formulation that enables comfortable administration for patients with severe cognitive disorder who reject medication, as it can be dissolved and swallowed with only a slight amount of saliva.
According to research, 35.6% of dementia patients also have dysphagia1), which makes it difficult for them to drink water. This condition must be considered when prescribing to such patients. For tablets that require water, smooth administration may be difficult.
70% of all patients with cognitive disorders also have xerostomia2). This means that the effects of the film formulation, a conventional alternative for patients with cognitive disorders, is limited, and new approaches are needed.1) Gil-Montoya, J.A., Barrios, R., Sánchez-Lara, I. et al. Prevalence of Drug-induced Xerostomia in Older Adults with Cognitive impairment or Dementia: An Observational Study, Drugs Aging 33, 611-618 (2016)
Research has found that low patient compliance is an obstacle to effective treatment. In the United States, the billions of dollars in costs generated annually by the need to provide additional prescriptions and to treat deteriorating conditions caused by low patient compliance is now emerging as a social issue. The approximate number of patients who die from such deterioration in conditions is 125,000 yearly.2)1) World Health Organization (2003). Adherence to long-term therapies: evidence for action. Geneva:World Health Organization.
We only have one solution. OD!FS®